Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy

Practical Radiation Oncology

Volumn 5, Issue 4, 2015, Pages e365-e373

  Mathieu, Dominique ^a   Campeau, Marie Pierre ^a   Bahig, Houda ^a   Larrivée, Sandra ^b   Vu, Toni ^a   Lambert, Louise ^a   Lavoie, Caroline ^c   Roberge, David ^a   Doucet, Robert ^a   Carrier, Jean François ^a   Gorgos, Andrei ^a   Fortin, Bernard ^a   Filion, Edith ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABLATION THERAPY; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; COUGHING; DISEASE FREE SURVIVAL; DYSPNEA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HISTOPATHOLOGY; HUMAN; LUNG DIFFUSION CAPACITY; MALE; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RIB FRACTURE; ROBOTICS; SCORING SYSTEM; STEREOTACTIC ABLATIVE RADIATION THERAPY; STEREOTACTIC TREATMENT; SYMPTOM; CARCINOMA, NON-SMALL-CELL LUNG; COMPUTER ASSISTED RADIOTHERAPY; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PROCEDURES; PSYCHOLOGY; ROBOTIC SURGICAL PROCEDURE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY, COMPUTER-ASSISTED; ROBOTIC SURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 84931277756     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2014.12.002     Document Type: Article

References (28)

1. Smythe W.R. Treatment of stage I non-small cell lung carcinoma. Chest 2003, 123:181S-187S. [Suppl.].
2. Armstrong J.G., Minsky B.D. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev 1989, 16(4):247-255.
3. Kaskowitz L., Graham M.V., Emami B., Halverson K.J., Rush C. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993, 27(3):517-523.
4. Dosoretz D.E., Katin M.J., Blitzer P.H., et al. Medically inoperable lung carcinoma: The role of radiation therapy. Semin Radiat Oncol 1996, 6(2):98-104.
5. Brown W.T., Wu X., Fayad F., et al. CyberKnife radiosurgery for stage I lung cancer: Results at 36 months. Clin Lung Cancer 2007, 8(8):488-492.
6. Lagerwaard F.J., Haasbeek C.J., Smit E.F., Slotman B.J., Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70(3):685-692.
7. Baumann P., Nyman J., Hoyer M., et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009, 27(20):3290-3296.
8. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004, 101(7):1623-1631.
9. Timmerman R., Michalski J., Galvin J., et al. RTOG 0236: A phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer. Proceedings of the 13th World Conference on Lung Cancer 2007.
10. van der Voort van Zyp N., Prévost J.B., van der Holt B., et al. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2010, 77(1):31-37.
11. Widder J., Postmus D., Ubbels J.F., Wiegman E.M., Langendijk J.A. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Int J Radiat Oncol Biol Phys 2011, 81(4):e291-e297.
12. Lagerwaard F.J., Aaronson N.K., Gundy C.M., Haasbeek C.J., Slotman B.J., Senan S. Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer. J Thorac Oncol 2012, 7(7):1148-1154.
13. Videtic G., Reddy C.A., Sorenson L. A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer. Support Care Cancer 2013, 21(1):211-218.
14. Henderson M., McGarry R., Yiannoutsos C., et al. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 72:404-409.
15. Stephans K.L., Djemil T., Reddy C.A., et al. Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J Thorac Oncol 2009, 4:838-844.
16. Bishawi M., Kim B., Moore W.H., Bilfinger T.V. Pulmonary function testing after stereotactic body radiotherapy to the lung. Int J Radiat Oncol Biol Phys 2012, 82(1):e107-e110.
17. Bahig H., Campeau M.P., Vu T., et al. Predictive parameters of CyberKnife fiducial-less (XSightLung) applicability for treatment of early non-small cell lung cancer: A single center experience. Int J Radiat Oncol Biol Phys 2013, 87:583-589.
18. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85(5):365-376.
19. Fayers P.M., Aaronson N.K., Bjordal K., Groenvold M., Curran D., Bottomley A. The EORTC QLQ-C30 Scoring Manual 2001, European Organization for Research and Treatment of Cancer, Brussels, Belgium.
20. Osoba D., Rodrigues G., Myles J., Zee B., Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998, 16(1):139-144.
21. Brunner E., Domhof S., Langer F. Nonparametric Analysis of Longitudinal Data in Factorial Experiments 2002, Wiley, Hoboken, NJ.
22. R Development Core Team R: A Language and Environment for Statistical Computing 2013, R Foundation for Statistical Computing, Vienna, Austria, Available at: http://www.R-project.org. Accessed in 2014.
23. Schemper M., Smith T.L. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996, 17(4):343-346.
24. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006, 24(30):4833-4839.
25. Dunlap N.E., Cai J., Biedermann G.B., et al. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010, 76(3):796-801.
26. Guckenberger M., Kestin L.L., Hope A.J., et al. Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer?. J Thorac Oncol 2012, 7(3):542-551.
27. Bahig H, Filion E, Vu T, et al. Excellent cancer outcomes following patient-adapted robotic lung SBRT but a case for caution in idiopathic pulmonary fibrosis [e-pub ahead of print]. Technol Cancer Res Treat. , accessed January 30, 2015. doi:10.7785/tcrt.2012.500445.
28. Öz G, Solak O, Metin M, Esme H, Sayar A. The effects of thoracic surgery operations on quality of life: A multicenter study [e-pub ahead of print]. Clin Respir J. , accessed in 2014. doi:10.1111/crj.12152.